Choroidal neovascularisation in pathological myopia: an update in management
- 1Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, People’s Republic of China
- 2Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, People’s Republic of China
- 3Department of Ophthalmology, Osaka University Medical School, Osaka, Japan
- Correspondence to: Professor Wai-Man Chan Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon, Hong Kong; cwm6373netvigator.com
- Accepted 1 July 2005
Abstract
Choroidal neovascularisation (CNV) secondary to pathological myopia is an important cause of significant visual impairment in young and middle aged adults globally and is particularly prevalent in Asian populations. In the past few years, there have been rapid advancements in the different treatments for myopic CNV. The purpose of this perspective is to give an overview of the natural history of myopic CNV and the various treatment options including laser photocoagulation, photodynamic therapy, submacular surgery, and macular translocation surgery. Future directions in the management of myopic CNV are also discussed.
- AMD, age related macular degeneration
- CNV, choroidal neovascularisation
- FA, fluorescein angiography
- ICG-A, indocyanine green angiography
- LMT, limited macular translocation
- MfERG, multifocal electroretinogram
- OCT, optical coherence tomography
- RPE, retinal pigment epithelium
- VA, visual acuity
- VEGF, vascular endothelial growth factor
- myopia
- choroidal neovascularisation
- photodynamic therapy
- surgery
- macular translocation
- AMD, age related macular degeneration
- CNV, choroidal neovascularisation
- FA, fluorescein angiography
- ICG-A, indocyanine green angiography
- LMT, limited macular translocation
- MfERG, multifocal electroretinogram
- OCT, optical coherence tomography
- RPE, retinal pigment epithelium
- VA, visual acuity
- VEGF, vascular endothelial growth factor
- myopia
- choroidal neovascularisation
- photodynamic therapy
- surgery
- macular translocation
Footnotes
-
Financial support: Supported by Competitive Earmarked Research Grant 4140/02M.
-
Competing interests: none declared
-
Financial interest: none







